40 related articles for article (PubMed ID: 27520960)
1. Erratum to: Heterodimer HLA-DM Fused with Constant Fragment of the Heavy Chain of the Human Immunoglobulin Accelerates Influenza Hemagglutinin Peptide HA
Mamedov AE; Ponomarenko NA; Belogurov AA; Gabibov AG
Bull Exp Biol Med; 2016 Jul; 161(3):442-446. PubMed ID: 27520960
[No Abstract] [Full Text] [Related]
2. Heterodimer HLA-DM Fused with Constant Fragment of the Heavy Chain of the Human Immunoglobulin Accelerates Influenza Hemagglutinin HA306-318 Loading to HLA-DR1.
Mamedov AE; Ponomarenko NA; Belogurov AA; Gabibov AG
Bull Exp Biol Med; 2016 May; 161(1):92-5. PubMed ID: 27265131
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
Newton-Nash DK; Eckels DD
J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides.
Li X; Li R; Li Z
Tissue Antigens; 2006 Jan; 67(1):45-52. PubMed ID: 16451200
[TBL] [Abstract][Full Text] [Related]
5. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
[TBL] [Abstract][Full Text] [Related]
6. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond.
Ferrante A; Gorski J
J Immunol; 2010 Feb; 184(3):1153-8. PubMed ID: 20038641
[TBL] [Abstract][Full Text] [Related]
8. High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR.
Roche PA; Cresswell P
J Immunol; 1990 Mar; 144(5):1849-56. PubMed ID: 2307844
[TBL] [Abstract][Full Text] [Related]
9. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
[TBL] [Abstract][Full Text] [Related]
10. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
Ghosh P; Amaya M; Mellins E; Wiley DC
Nature; 1995 Nov; 378(6556):457-62. PubMed ID: 7477400
[TBL] [Abstract][Full Text] [Related]
11. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line.
Dodi AI; Brett S; Nordeng T; Sidhu S; Batchelor RJ; Lombardi G; Bakke O; Lechler RI
Eur J Immunol; 1994 Jul; 24(7):1632-9. PubMed ID: 8026524
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of a structural homology model for a class II histocompatibility protein, HLA-DR1: comparison to the crystal structure.
Nauss JL; Reid RH; Sadegh-Nasseri S
J Biomol Struct Dyn; 1995 Jun; 12(6):1213-33. PubMed ID: 7669268
[TBL] [Abstract][Full Text] [Related]
13. A cyclic peptide accelerates the loading of peptide antigens in major histocompatibility complex class II molecules.
Afridi S; Shaheen F; Roetzschke O; Shah ZA; Abbas SC; Siraj R; Makhmoor T
Biochem Biophys Res Commun; 2015 Jan; 456(3):774-9. PubMed ID: 25522880
[TBL] [Abstract][Full Text] [Related]
14. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
Schafer PH; Green JM; Malapati S; Gu L; Pierce SK
J Immunol; 1996 Dec; 157(12):5487-95. PubMed ID: 8955198
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the immune response induced by a single xenoantigen in vivo.
Sireci G; Dieli F; Barera A; Di Sano C; Bonanno CT; Salerno A
Immunol Lett; 2005 May; 98(2):245-52. PubMed ID: 15860224
[TBL] [Abstract][Full Text] [Related]
16. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
17. Influenza A hemagglutinin-specific T cell clones strictly restricted by HLA-DR1 or HLA-DR7 molecules.
Sterkers G; Henin Y; Lepage V; Fradelizzi D; Hannoun C; Levy JP
Eur J Immunol; 1984 Feb; 14(2):125-32. PubMed ID: 6199211
[TBL] [Abstract][Full Text] [Related]
18. Stable expression of MHC class I heavy chain/HLA-DO complexes at the plasma membrane.
van Lith M; van Ham M; Neefjes J
Eur J Immunol; 2003 May; 33(5):1145-51. PubMed ID: 12731039
[TBL] [Abstract][Full Text] [Related]
19. Nested polymerase chain reaction amplification and sequencing analysis of the light-chain and heavy-chain variable regions in the influenza A H1N1 virus hemagglutinin monoclonal antibody gene.
Li HJ; Guo CY; Sun JY; Sun LJ; Zhao PH; Hu L; Li Y; Hu J
Genet Mol Res; 2014 Jun; 13(2):4372-9. PubMed ID: 25036343
[TBL] [Abstract][Full Text] [Related]
20. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
